News Eyes on GSK as Pfizer prepares to sell consumer division GlaxoSmithKline saw its share price fall 6% yesterday after releasing underwhelming figures in Q3, and leaving investors uncertain about its future dividend payments.
News GSK’s ‘bubble baby’ gene therapy passes NICE’s new stricter ... GlaxoSmithKline’s gene therapy Strimvelis for the treatment of the ultra-rare ‘bubble baby syndrome’ has been approved by NICE.
News FDA approval gained, Glaxo awaits key committee blessing for... The FDA granted approval to GSK's new shingles vaccine Shingrix on Friday, giving the company the green light on one of its important new products.
Partner Content Partner Content Have you seen the agenda for Social Media in Pharma? Updates on Social Media in Pharma
News Tipped to hit $1bn, GSK’s Shingrix gains committee approval GlaxoSmithKline’s shingles vaccine Shingrix has gained the unanimous backing of an FDA advisory committee.
News GSK and Propeller prepare to launch digital inhaler Deal expands to a commercialisation partnership to prepare for US and Europe marketing.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.